Chase C. Leavitt
General Counsel, Lineage Cell Therapeutics.
Companies
- Mobia Medical, Inc.Officer May 7, 2026 to now1
- Oncternal Therapeutics, Inc.General counsel May 27, 2021 to Feb 15, 20242
- Lineage Cell TherapeuticsGeneral counsel May 22, 2019 to Mar 17, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mobia Medical, Inc. MOBI5,000 shares4$43.7K at $8.73Sep 11, 2026
- Oncternal Therapeutics, Inc.84,758 shares5Jan 3, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 11, 2026Bought 2,000 shares at $10.30 of Mobia Medical, Inc.4
- May 11, 2026Bought 3,000 shares at $15.00 of Mobia Medical, Inc.6
- Jan 3, 2024Shares withheld for tax 11,838 shares at $0.50 of Oncternal Therapeutics, Inc.5
- Jul 3, 2023Shares withheld for tax 10,305 shares at $0.36 of Oncternal Therapeutics, Inc.7
- Apr 13, 2023Bought 10,000 shares at $0.29 of Oncternal Therapeutics, Inc.8
- Apr 12, 2023Bought 15,000 shares at $0.29 of Oncternal Therapeutics, Inc.8
- Jan 3, 2023Shares withheld for tax 6,091 shares at $1.02 of Oncternal Therapeutics, Inc.9
- Jul 28, 2022Granted 43,125 shares of Oncternal Therapeutics, Inc.10
- Jan 28, 2022Bought 5,000 shares at $1.63 of Oncternal Therapeutics, Inc.11
- Jan 27, 2022Bought 8,500 shares at $1.78 of Oncternal Therapeutics, Inc.11
- Jan 3, 2022Granted 29,867 shares of Oncternal Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMobia Medical, Inc., Officer
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed May 11, 2026
- 7SEC EDGARForm 4 filed Jul 5, 2023
- 8SEC EDGARForm 4 filed Apr 14, 2023
- 9SEC EDGARForm 4 filed Jan 5, 2023
- 10SEC EDGARForm 4 filed Aug 1, 2022
- 11SEC EDGARForm 4 filed Jan 31, 2022
- 12SEC EDGARForm 4 filed Jan 5, 2022